(NYSEMKT: STXS) Stereotaxis's forecast annual revenue growth rate of 34.77% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 2.79%, and it is also forecast to beat the US market's average forecast revenue growth rate of 18.69%.
Stereotaxis's revenue in 2026 is $30,067,000.On average, 5 Wall Street analysts forecast STXS's revenue for 2026 to be $3,509,080,274, with the lowest STXS revenue forecast at $3,289,637,504, and the highest STXS revenue forecast at $3,682,430,042. On average, 7 Wall Street analysts forecast STXS's revenue for 2027 to be $5,427,150,365, with the lowest STXS revenue forecast at $4,713,510,453, and the highest STXS revenue forecast at $6,249,609,842.
In 2027, STXS is forecast to generate $4,667,417,451 in revenue, with the lowest revenue forecast at $4,271,618,848 and the highest revenue forecast at $4,944,977,484.